Before proceeding, please note: If you are not a current client of Orrick, please do not include any information in this email that you or someone else considers to be confidential or secret in nature. Prior to the establishment of a lawyer-client relationship, unsolicited emails from non-clients containing confidential or secret information cannot be protected from disclosure.

OK
Cancel
Events

​Total Access Japan: Investing in Regenerative Medicine in Japan

Orrick's Total Access Japan Event Series provides entrepreneurs business, tactical, and legal education through complimentary panels and seminars and networking events.
The next event will take place on Wednesday, May 30 from 6:00 pm to 7:30 pm.

As biotech companies race toward the opportunities in Japan, no life sciences sector has received more attention, government support, and regulatory reform than the important field of regenerative medicine. The Japanese government wants to be the regenerative medicine center of the world. To do that, the Japanese government is keen to entice companies to come to Japan and for Japan’s own pharmaceutical companies to develop and license in the best medicines. The “regen” boom in Japan is based on a series of reforms and new laws for pharmaceuticals, but especially the landmark Pharmaceuticals and Medical Devices Act (PMD Act) and the Act on the Safety of Regenerative Medicine. The legislation focuses on everything from basic research to clinical research/trials, approval reviews, safety measures, insurance coverage, improvement of infrastructure and the environment for corporate activities, and global expansion.

During this session, speakers will discuss why the Japan regenerative market is attractive, the up-and-coming companies active in market, and the factors the speakers consider when investing in or acquiring a regenerative company.

Guest Speakers:
Fred Shane, Managing Partner, Axil Capital Partners
Rob Claar, Chief Executive Officer, HekaBio K.K.
Izumi Sakakibara, Regenerative Medicine Business Division, Pharmaceutial Product Division, Fujifilm Corporation

Orrick Speakers:
David Case, Partner, Tokyo Office
Hiroki Sugita, Partner, Tokyo Office

Date & Time: Wednesday, May 30 from 6:00 pm – 7:30 pm
Location: Orrick Tokyo Offices (Map)
Language: English and/or Japanese (no simultaneous interpretation)
Fee: Free of charge
Registration: RSVP by May 28 (Monday)

For questions, please contact Aya Mori

Date & Time

30.05.2018 6:00 PM